Maximus markets several testosterone-related treatments, including an oral testosterone program. A daily pill may sound simpler than injections, but the important comparison includes the formulation, medical follow-up, and payment commitment as well as the route.
This review focuses on the current oral testosterone page and the broader treatment catalog. It does not treat company outcome claims as independently verified clinical results, and it does not assume that a compounded oral preparation has the evidence or approval status of a different oral testosterone medicine.
- The oral product is described as custom compounded.
- The first-month offer differs from the recurring plan rate.
- Hormone and fertility-marker claims do not guarantee clinical outcomes.
Identify which Maximus program you mean
The catalog includes testosterone cream, injections, oral testosterone, and enclomiphene. Those are not interchangeable products. Enclomiphene works through hormone signaling rather than supplying testosterone itself. A review of the oral testosterone program should therefore not quietly become a recommendation for every item in the catalog.
Ask for the complete proposed prescription, including any accompanying drug. If a consultation leads to a different treatment, start the comparison again with that formulation. Our testosterone medication guide gives the vocabulary for that conversation without telling you which product to select.
The oral program is described as compounded
Maximus identifies its oral formulation as custom compounded and describes dispensing through licensed US compounding pharmacies. That is a useful disclosure, but pharmacy licensing and FDA approval of a finished drug are different matters. Compounded medicines do not receive the same premarket FDA review as approved products.
Do not transfer the label, food instructions, evidence, or dosing schedule of an approved testosterone undecanoate capsule to this preparation. Ask for the exact ingredient and formulation, the dispensing pharmacy, storage instructions, and the reason it is being proposed. Our compounding comparison explains the distinction at more length.
Separate the introductory offer from the ongoing plan
At this check, the oral page displayed $249.99 for a one-month plan, $199.99 per month for a three-month plan, and $149.99 per month for a six-month plan. It also promoted a $74.99 first month on the six-month plan, followed by $149.99 monthly. The page notes that pricing can vary with dose, plan length, and state.
These displayed amounts do not establish the total amount collected at checkout, the cost of every required laboratory test, or your cancellation liability. Ask for each of those details. A first-month discount is not a sustainable monthly price, and a monthly equivalent should not be compared with another clinic’s first invoice without adjusting for what each includes.
For a realistic budget, write the ordinary rate in one column and introductory savings in another. List testing and any additional prescription separately until the provider confirms inclusion. The annual worksheet can help with the arithmetic, but it cannot fill an unknown cost with a reliable number.
Read outcome claims with the right questions
The oral page describes hormone changes and links company research. A reported change in a hormone measurement does not by itself establish how much a patient’s symptoms improved, how long an effect lasted, or whether uncommon harms were captured. It also does not prove that this program outperforms another clinic’s care.
Ask whether evidence concerns the exact prescription being offered, who was included, what was measured, and whether there was a suitable comparison group. A chart about testosterone levels may be relevant to a laboratory effect while leaving questions about daily function unanswered. We did not independently reproduce the company’s findings or conduct a systematic evidence review of its formulation.
Fertility needs a separate discussion
The company discusses fertility markers in connection with its protocol. Markers are not a guarantee of preserved sperm production or future pregnancy. The Endocrine Society advises against starting testosterone therapy in men planning fertility in the near term. Tell the prescriber about your plans before paying for a long commitment.
If an accompanying medicine is proposed to address fertility concerns, ask what it can and cannot establish in your case. You may need a reproductive specialist’s input and testing beyond routine testosterone measurements. Our TRT and fertility guide is a starting point for that conversation, not a substitute for it.
Monitoring and everyday logistics
The oral program describes laboratory testing before and during care. Ask who interprets the results, when the next review is expected, and how you obtain help between appointments. Blood pressure and other safety checks remain relevant when medication is taken by mouth. A needle-free route does not remove the need to review risks.
Also ask about missed doses, travel, storage, and meal instructions for the actual prescription. Have the pharmacist explain any part of the label that is difficult to follow. If a routine will be awkward in your daily life, say so before selecting it; convenience should be assessed against what you would actually need to do.
Our assessment
Maximus offers a clearly identifiable compounded oral option and several advertised plan lengths. It deserves a careful formulation-specific conversation for readers comparing routes, rather than a blanket endorsement based on the appeal of a pill. The open questions include your complete bill, your pharmacy product, and whether the treatment is medically suitable.
Use the treatment-options shortlist to compare what clinics publish. Then ask the clinician to explain the choice in your case, how benefit will be assessed, and what would lead to reconsideration. Those answers are more useful than a promise to reach a particular testosterone number.
Sources & reading notes
Provider pages describe advertised services, not independently verified outcomes. Prices and eligibility may change. Checked September 20, 2026.